Logo image of DLB

DOLBY LABORATORIES INC-CL A (DLB) Stock Fundamental Analysis

NYSE:DLB - New York Stock Exchange, Inc. - US25659T1079 - Common Stock - Currency: USD

75.34  +0.36 (+0.48%)

After market: 75.34 0 (0%)

Fundamental Rating

7

DLB gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. DLB gets an excellent profitability rating and is at the same time showing great financial health properties. DLB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year DLB was profitable.
DLB had a positive operating cash flow in the past year.
Each year in the past 5 years DLB has been profitable.
Each year in the past 5 years DLB had a positive operating cash flow.
DLB Yearly Net Income VS EBIT VS OCF VS FCFDLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

DLB has a better Return On Assets (8.32%) than 82.33% of its industry peers.
DLB's Return On Equity of 10.47% is fine compared to the rest of the industry. DLB outperforms 77.39% of its industry peers.
DLB's Return On Invested Capital of 8.44% is amongst the best of the industry. DLB outperforms 81.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DLB is below the industry average of 12.01%.
The 3 year average ROIC (8.02%) for DLB is below the current ROIC(8.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.32%
ROE 10.47%
ROIC 8.44%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
DLB Yearly ROA, ROE, ROICDLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

DLB has a Profit Margin of 19.97%. This is amongst the best in the industry. DLB outperforms 86.22% of its industry peers.
In the last couple of years the Profit Margin of DLB has remained more or less at the same level.
DLB has a Operating Margin of 21.10%. This is amongst the best in the industry. DLB outperforms 89.40% of its industry peers.
DLB's Operating Margin has declined in the last couple of years.
DLB has a Gross Margin of 88.65%. This is amongst the best in the industry. DLB outperforms 95.41% of its industry peers.
DLB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.1%
PM (TTM) 19.97%
GM 88.65%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
DLB Yearly Profit, Operating, Gross MarginsDLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DLB is destroying value.
DLB has less shares outstanding than it did 1 year ago.
DLB has less shares outstanding than it did 5 years ago.
DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DLB Yearly Shares OutstandingDLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DLB Yearly Total Debt VS Total AssetsDLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DLB has an Altman-Z score of 8.82. This indicates that DLB is financially healthy and has little risk of bankruptcy at the moment.
DLB has a better Altman-Z score (8.82) than 84.81% of its industry peers.
There is no outstanding debt for DLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.82
ROIC/WACC0.78
WACC10.81%
DLB Yearly LT Debt VS Equity VS FCFDLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 2.91 indicates that DLB has no problem at all paying its short term obligations.
DLB has a better Current ratio (2.91) than 73.14% of its industry peers.
A Quick Ratio of 2.84 indicates that DLB has no problem at all paying its short term obligations.
The Quick ratio of DLB (2.84) is better than 73.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.84
DLB Yearly Current Assets VS Current LiabilitesDLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.94% over the past year.
DLB shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.26% yearly.
Looking at the last year, DLB shows a decrease in Revenue. The Revenue has decreased by -2.00% in the last year.
DLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.51% yearly.
EPS 1Y (TTM)14.94%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%5.51%
Revenue 1Y (TTM)-2%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%1.38%

3.2 Future

Based on estimates for the next years, DLB will show a small growth in Earnings Per Share. The EPS will grow by 7.08% on average per year.
The Revenue is expected to grow by 4.87% on average over the next years.
EPS Next Y7.47%
EPS Next 2Y6.91%
EPS Next 3Y7.08%
EPS Next 5YN/A
Revenue Next Year5.81%
Revenue Next 2Y5.25%
Revenue Next 3Y4.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLB Yearly Revenue VS EstimatesDLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
DLB Yearly EPS VS EstimatesDLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.84, which indicates a rather expensive current valuation of DLB.
80.57% of the companies in the same industry are more expensive than DLB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 24.21, DLB is valued a bit cheaper.
DLB is valuated rather expensively with a Price/Forward Earnings ratio of 17.35.
81.63% of the companies in the same industry are more expensive than DLB, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, DLB is valued at the same level.
Industry RankSector Rank
PE 18.84
Fwd PE 17.35
DLB Price Earnings VS Forward Price EarningsDLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DLB is valued cheaply inside the industry as 81.98% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DLB is valued cheaper than 84.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.39
EV/EBITDA 18.76
DLB Per share dataDLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DLB does not grow enough to justify the current Price/Earnings ratio.
DLB has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.52
PEG (5Y)2.03
EPS Next 2Y6.91%
EPS Next 3Y7.08%

5

5. Dividend

5.1 Amount

DLB has a Yearly Dividend Yield of 1.76%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 13.67, DLB pays a better dividend. On top of this DLB pays more dividend than 95.76% of the companies listed in the same industry.
DLB's Dividend Yield is slightly below the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.76%

5.2 History

On average, the dividend of DLB grows each year by 9.47%, which is quite nice.
DLB has paid a dividend for at least 10 years, which is a reliable track record.
As DLB did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)9.47%
Div Incr Years9
Div Non Decr Years9
DLB Yearly Dividends per shareDLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DLB pays out 44.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of DLB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP44.76%
EPS Next 2Y6.91%
EPS Next 3Y7.08%
DLB Yearly Income VS Free CF VS DividendDLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
DLB Dividend Payout.DLB Dividend Payout, showing the Payout Ratio.DLB Dividend Payout.PayoutRetained Earnings

DOLBY LABORATORIES INC-CL A

NYSE:DLB (5/9/2025, 8:04:00 PM)

After market: 75.34 0 (0%)

75.34

+0.36 (+0.48%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners92.74%
Inst Owner Change1.4%
Ins Owners1.12%
Ins Owner Change8.42%
Market Cap7.26B
Analysts82.5
Price Target99.45 (32%)
Short Float %2.12%
Short Ratio2.63
Dividend
Industry RankSector Rank
Dividend Yield 1.76%
Yearly Dividend1.2
Dividend Growth(5Y)9.47%
DP44.76%
Div Incr Years9
Div Non Decr Years9
Ex-Date05-13 2025-05-13 (0.33)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.14%
Min EPS beat(2)7.16%
Max EPS beat(2)15.12%
EPS beat(4)4
Avg EPS beat(4)11.7%
Min EPS beat(4)5.37%
Max EPS beat(4)19.15%
EPS beat(8)7
Avg EPS beat(8)14.03%
EPS beat(12)10
Avg EPS beat(12)14%
EPS beat(16)13
Avg EPS beat(16)15.46%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-2%
Max Revenue beat(2)2.11%
Revenue beat(4)2
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-2%
Max Revenue beat(4)2.11%
Revenue beat(8)3
Avg Revenue beat(8)0.47%
Revenue beat(12)4
Avg Revenue beat(12)-0.06%
Revenue beat(16)6
Avg Revenue beat(16)-0.07%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.4%
EPS NY rev (1m)-0.66%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.79%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 18.84
Fwd PE 17.35
P/S 5.52
P/FCF 18.39
P/OCF 17.06
P/B 2.9
P/tB 4.64
EV/EBITDA 18.76
EPS(TTM)4
EY5.31%
EPS(NY)4.34
Fwd EY5.76%
FCF(TTM)4.1
FCFY5.44%
OCF(TTM)4.42
OCFY5.86%
SpS13.65
BVpS26.02
TBVpS16.25
PEG (NY)2.52
PEG (5Y)2.03
Profitability
Industry RankSector Rank
ROA 8.32%
ROE 10.47%
ROCE 10.21%
ROIC 8.44%
ROICexc 10.44%
ROICexgc 18.28%
OM 21.1%
PM (TTM) 19.97%
GM 88.65%
FCFM 30.03%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
ROICexc(3y)11.36%
ROICexc(5y)12.88%
ROICexgc(3y)17.78%
ROICexgc(5y)19.47%
ROCE(3y)9.71%
ROCE(5y)9.93%
ROICexcg growth 3Y-12.75%
ROICexcg growth 5Y-4.71%
ROICexc growth 3Y-18.76%
ROICexc growth 5Y-8.2%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 38.34%
Cap/Sales 2.33%
Interest Coverage 250
Cash Conversion 119.04%
Profit Quality 150.36%
Current Ratio 2.91
Quick Ratio 2.84
Altman-Z 8.82
F-Score7
WACC10.81%
ROIC/WACC0.78
Cap/Depr(3y)47.88%
Cap/Depr(5y)55.27%
Cap/Sales(3y)3.14%
Cap/Sales(5y)3.93%
Profit Quality(3y)140.69%
Profit Quality(5y)133.53%
High Growth Momentum
Growth
EPS 1Y (TTM)14.94%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%5.51%
EPS Next Y7.47%
EPS Next 2Y6.91%
EPS Next 3Y7.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-2%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%1.38%
Revenue Next Year5.81%
Revenue Next 2Y5.25%
Revenue Next 3Y4.87%
Revenue Next 5YN/A
EBIT growth 1Y15.04%
EBIT growth 3Y-8.08%
EBIT growth 5Y-2.06%
EBIT Next Year32.55%
EBIT Next 3Y15.82%
EBIT Next 5YN/A
FCF growth 1Y30.56%
FCF growth 3Y-8.91%
FCF growth 5Y6.77%
OCF growth 1Y23.98%
OCF growth 3Y-9.93%
OCF growth 5Y-0.03%